Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Debt to Equity (2016 - 2025)

Xtant Medical Holdings has reported Debt to Equity over the past 16 years, most recently at $0.43 for Q4 2025.

  • Quarterly Debt to Equity fell 45.98% to $0.43 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.43 through Dec 2025, down 45.98% year-over-year, with the annual reading at $0.43 for FY2025, 45.98% down from the prior year.
  • Debt to Equity was $0.43 for Q4 2025 at Xtant Medical Holdings, down from $0.57 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.8 in Q4 2024 and troughed at $0.34 in Q3 2023.
  • The 5-year median for Debt to Equity is $0.51 (2021), against an average of $0.53.
  • The largest YoY upside for Debt to Equity was 129.7% in 2021 against a maximum downside of 72.0% in 2021.
  • A 5-year view of Debt to Equity shows it stood at $0.5 in 2021, then decreased by 23.35% to $0.38 in 2022, then rose by 10.97% to $0.42 in 2023, then skyrocketed by 87.37% to $0.8 in 2024, then crashed by 45.98% to $0.43 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Debt to Equity are $0.43 (Q4 2025), $0.57 (Q3 2025), and $0.71 (Q2 2025).